everybody, welcome back to Psychedelics today. Joe Moore here, joined by Josh Lipson. How are you today?

I'm good. I'm good. Really glad to be here.

I've been looking forward. Yeah, this is going to be fun. So we had the opportunity to meet at the

Penn Psychedelic Conference that happened recently, Philadelphia. Sorry, I almost got the

missed the name. And we had the opportunity to chat a bit about your work and you're wrapping up a PhD at Columbia.

You're in the very final stages of that.

Can you tell us a little bit about what you've been working on?

Sure.

Yeah.

So I am finishing up my PhD in clinical psychology at Columbia. So both getting clinical training,

doing all kinds of psychotherapy and assessment that is not psychedelic in any way directly.

And also doing research in many different directions under the auspices of the spirituality and psychology lab.

And my research program has talked about the relationship between mystical and self-transcendant experiences generally and mental health well-being, but also has honed in on

psychedelic experiences, whether they are mystical or not, and their diverse impact on people

down the line. This is something that is getting bigger and bigger

as an arena under investigation.

But to this day, I still think there's a lot

we haven't mapped out.

And I think my main project is really trying to contribute

with nuance and open-mindedness

to a mapping out of the possibility space

of what happens when people take a psychedelic,

...